Improving patient outcomes in moderate-to-severe ulcerative colitis

touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to leading experts discuss important considerations in the optimal management of patients with moderate-to-severe ulcerative colitis. The experts Prof. Ailsa Hart – St Mark’s Hospital and Academic Institute, London, UK Dr Gil Y Melmed – Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA Prof. Brian G Feagan – University of Western Ontario, London, ON, Canada This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent educational grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchimmunologyime.org/improving-outcomes-uc